This Company Is Positioned for Healthy Growth
Becoming an integrated health care provider could be a winning strategy for CVS Caremark.
Can These Obesity Drug Stocks Bounce Back in 2014?
It’s been a brutal 12 months for Arena and VIVUS, which respectively sell the obesity drugs Belviq and Qsymia. Can these two beaten-down stocks bounce back in 2014?